Efficacy and tolerability of natalizumab in relapsing–remitting multiple sclerosis patients: a post-marketing observational study

✍ Scribed by F. Sangalli; L. Moiola; S. Bucello; P. Annovazzi; A. Rizzo; M. Radaelli; G. Vitello; L. M. E. Grimaldi; A. Ghezzi; V. Martinelli; G. Comi

• Publisher: Springer Milan
• Year: 2010
• Tongue: English
• Weight: 238 KB
• Volume: 31
• Category: Article
• ISSN: 1590-1874
• DOI: 10.1007/s10072-010-0344-z